Therapeutic Options for the SARS-CoV-2 Virus: Is There a Key in Herbal Medicine?

被引:2
|
作者
Sharma, Nitin [1 ]
Kulkarni, Giriraj T. [2 ]
Bhatt, Anant Narayan [3 ]
Satija, Saurabh [4 ,5 ]
Singh, Lubhan [6 ]
Sharma, Anjana [7 ]
Dua, Kamal [4 ]
Karwasra, Ritu [8 ]
Khan, Asim Ali [8 ]
Ahmad, Nadeem [9 ]
Raza, Khalid [10 ]
机构
[1] ISF Coll Pharm, Dept Pharmaceut, Moga, Punjab, India
[2] Gokaraju Rangaraju Coll Pharm, Hyderabad, Telangana, India
[3] Def Res & Dev Org, Dept Nucl Med, Inst Nucl Med & Allied Sci, Delhi, India
[4] Univ Technol Sydney, Grad Sch Hlth, Discipline Pharm, Ultimo, NSW, Australia
[5] Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara, Punjab, India
[6] Swami Vivekanand Subharti Univ, KharvelSubharti Coll Pharm, Dept Pharmacol, Meerut, Uttar Pradesh, India
[7] Meerut Inst Engn & Technol, Dept Pharmaceut Technol, Meerut, UP, India
[8] Govt India, Cent Council Res Unani Med CCRUM, Minist AYUSH, New Delhi, India
[9] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India
[10] Jamia Millia Islamia, Dept Comp Sci, New Delhi 110025, India
关键词
SARS-CoV-2; herbal medicine; natural product; coronavirus; pneumonia; GLYCYRRHIZIC ACID; BETULINIC ACID; CORONAVIRUS SARS-COV-2; ENTEROVIRUS; 71; IN-VITRO; DERIVATIVES; PHARMACOLOGY; INHIBITORS; HESPERIDIN; LYCORINE;
D O I
10.1177/1934578X221126303
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
SARS-CoV-2 has been responsible for over 500 million cumulative cases all over the world since December 2019 and has marked the third introduction of a highly pathogenic virus after SARS-CoV and MERS-CoV. This virus is in a winning situation because scientists are still racing to explore effective therapeutics, vaccines, and event treatment regimens. In view of progress in current disease management, until now none of the preventive/treatment measures can be considered entirely effective to treat SARS-CoV-2 infection. Therefore, it is required to look up substitute ways for the management of this disease. In this context, herbal medicines could be a good choice. This article emphasizes the antiviral potential of some herbal constituents which further can be a drug of choice in SARS-CoV-2 treatment. This article may be a ready reference for discovering natural lead compounds and targets in SARS-CoV-2 associated works.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?
    Onay, Ahmet
    Ertas, Abdulselam
    Suzerer, Veysel
    Yener, Ismail
    Yilmaz, Mustafa Abdullah
    Ayaz-Tilkat, Emine
    Ekinci, Remzi
    Bozhan, Nesrin
    Irtegun-Kandemir, Sevgi
    TURKISH JOURNAL OF BIOLOGY, 2021, 45 (04) : 570 - 587
  • [42] Engineered Therapeutic Antibody Against SARS-CoV-2
    Monrat Chulanetra
    Current Clinical Microbiology Reports, 2023, 10 : 222 - 235
  • [43] An intranasal ASO therapeutic targeting SARS-CoV-2
    Chi Zhu
    Justin Y. Lee
    Jia Z. Woo
    Lei Xu
    Xammy Nguyenla
    Livia H. Yamashiro
    Fei Ji
    Scott B. Biering
    Erik Van Dis
    Federico Gonzalez
    Douglas Fox
    Eddie Wehri
    Arjun Rustagi
    Benjamin A. Pinsky
    Julia Schaletzky
    Catherine A. Blish
    Charles Chiu
    Eva Harris
    Ruslan I. Sadreyev
    Sarah Stanley
    Sakari Kauppinen
    Silvi Rouskin
    Anders M. Näär
    Nature Communications, 13
  • [44] An intranasal ASO therapeutic targeting SARS-CoV-2
    Zhu, Chi
    Lee, Justin Y.
    Woo, Jia Z.
    Xu, Lei
    Nguyenla, Xammy
    Yamashiro, Livia H.
    Ji, Fei
    Biering, Scott B.
    Van Dis, Erik
    Gonzalez, Federico
    Fox, Douglas
    Wehri, Eddie
    Rustagi, Arjun
    Pinsky, Benjamin A.
    Schaletzky, Julia
    Blish, Catherine A.
    Chiu, Charles
    Harris, Eva
    Sadreyev, Ruslan I.
    Stanley, Sarah
    Kauppinen, Sakari
    Rouskin, Silvi
    Naar, Anders M.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [45] Therapeutic antibodies under development for SARS-CoV-2
    Ma, Zetong
    Zhu, MengMei
    Zhang, Shuyi
    Qian, Kewen
    Wang, Chuqi
    Fu, Wenyan
    Lei, Changhai
    Hu, Shi
    VIEW, 2022, 3 (02)
  • [46] Engineered Therapeutic Antibody Against SARS-CoV-2
    Chulanetra, Monrat
    CURRENT CLINICAL MICROBIOLOGY REPORTS, 2023, 10 (04) : 222 - 235
  • [47] SARS-CoV-2 and UPS with potentials for therapeutic interventions
    Ferdoush, Jannatul
    Kadir, Rizwaan Abdul
    Kaplanoglu, Selin Simay
    Osborn, Morgan
    GENE, 2024, 912
  • [48] Potential Therapeutic Target and Vaccines for SARS-CoV-2
    Hussain, Mohamed A.
    Hassan, Mohamed M.
    Bashir, Bashir Abdrhman
    Gamar, Tarig A.
    Gasmalbari, Elmuaiz
    Mohamed, Ahmed Osman
    Osman, Wadah
    Sherif, Asmaa E.
    Elgaml, Abdelaziz
    Alhaddad, Aisha A.
    Ghazawi, Kholoud F.
    Miski, Samar F.
    Ainousah, Bayan E.
    Andijani, Yusra Saleh
    Ibrahim, Sabrin R. M.
    Mohamed, Gamal A.
    Ashour, Ahmed
    PATHOGENS, 2023, 12 (07):
  • [49] Chewable tablet with herbal extracts and propolis arrests Wuhan and Omicron variants of SARS-CoV-2 virus
    Karaoglu, Oznur
    Serhatli, Muge
    Pelvan, Ebru
    Karadeniz, Bulent
    Demirtas, Ilknur
    Cakirca, Gamze
    Sipahi, Hande
    Ozhan, Yagmur
    Karapinar, Gozdem
    Charehsaz, Mohammad
    Aydin, Ahmet
    Yesilada, Erdem
    Alasalvar, Cesarettin
    JOURNAL OF FUNCTIONAL FOODS, 2023, 105
  • [50] Uncaria tomentosa (cat's claw): a promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling
    Yepes-Perez, Andres F.
    Herrera-Calderon, Oscar
    Quintero-Saumeth, Jorge
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (05): : 2227 - 2243